Parsons AS, Morris CD, Bryan K, Durning SJ, Van Mook WN, Ryan MS, Abdoler E. There’s no one right answer: A Qualitative Exploration of How Postgraduate Medical Trainees Conceptualize Management Reasoning. Med Educ. May 2025 (Under Review).
Young, S., Dougherty, S., DeRidder, A., Fadul, C., Gentzler, R., (2025) Successful Treatment of Innumerable Untreated Brain Metastases with Trastuzumab Deruxtecan in Chemotherapy-Naïve HER2- Mutated Non-Small Cell Lung Cancer. Case Reports in Oncological Medicine. doi.org/10.1155/crom/9936011
Bolte, F.J., Luminais C.K., Mistro, M., Devitt, M.E., MRI-Guided Adaptive Radiation Therapy for Oligometastatic Prostate Cancer Involving the Adrenal Gland: A Case Report and Literature Review. Case Rep Oncol. https://doi.org/10.1159/000545983. Online ahead of print.
Dougherty, S.*, Bolte, F.*, Danos, A., Lynch, A., Shvorak, Y., Statler, S., Gentzler, R., Hall, R., (2025) Real-World Outcomes of Tarlatamab in Small Cell Lung Cancer, Including Patients with Untreated Brain Metastases. Clinical Lung Cancer. doi: 10.1016/j.cllc.2025.03.006. *These authors contributed equally.
Dougherty, S., Gentzler, R., (2024) Osimertinib for Uncommon EGFR Mutations: Herding UNICORNs in a Field of Horses. Translational Cancer Research. doi: 10.21037/tcr-24-1936
Michaels, K., Dougherty, S., Kurpiel, B., Douvas, M., (2024) Primary Mediastinal Synovial Sarcoma with Pericardial Involvement: A Case Report. Case Reports in Oncology. doi.org/10.1159/00054268
Morris CD, Humphrey C, Dillon P. A comprehensive review of current treatment modalities for leptomeningeal carcinomatosis in breast cancer. Crit Rev Oncol Hematol. 2024 Dec;204:104513. doi: 10.1016/j.critrevonc.2024.104513. Epub 2024 Sep 14. PMID: 39278427.
Dougherty, S., Flowers, W., Gaughan, E., (2024) Precision Oncology in Melanoma: Changing Practices. Journal of Nuclear Medicine. doi: 10.2967/jnumed.124.267781
Schlefman J, Davidson K. Protein C Deficiency. Clinical Overview. Elsevier Clinical Key. 2024.
Schlefman J, Brenin C, Millard T, Dillon P. Estrogen Receptor Positive Breast Cancer: Contemporary Nuances to Sequencing Therapy. Med Oncol. 2023 Dec; 41(1):19.
Schlefman J, Man L. Advances in Treatment of Hemophilia. Clinical Hematology Update. NEJM Group. 2023.
Shantzer LB, Dougherty SC, Bolte FJ, et al. Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report. Clin Lung Cancer. 2023;24(2).
Ladwa, A, Elghawy O, Schroen A, Abernathy K, Schlefman J, Dillon P. Complete Response of Triple-Negative Metaplastic Carcinoma of the Breast Using Pembrolizumab. Case Rep Oncol. 2023 March;16(1):1129-1135.
Bolte FJ, Hall RD, Shah NL. Immune checkpoint inhibitor-related liver toxicity. Clin Liver Dis (Hoboken). 2022;20(3):93-6.
Bolte FJ, McTavish S, Wakefield N, et al. Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy. Front Oncol. 2022;12:986236
Schlefman J, Maheshwari S, Jones C, Burgess I, Guishard A, Grubbs C, Kauffman J, Whitman A, Campbell G, Keng M. Reduction in Discharge Delays for Patients Admitted for Allogeneic and Autologous Stem Cell Transplantation: A Quality Improvement Initiative; Transplantation and Cellular Therapy Meetings 2025, Honolulu, HI. (Poster)
Maheshwari S, Schlefman J, Jones C, Burgess I, Guishard A, Grubbs C, Kauffman J, Whitman A, Campbell G, Keng M. Improving Discharge Times for Patients Admitted for Allogeneic Stem Cell Transplantation; American Society of Clinical Oncology Quality Care Symposium 2024, San Francisco, CA. (Poster)
Turkheimer L, Schlefman J,* Millard T, Petroni G, Brighton D, Showalter S. The Pre-Operative Window of Endocrine Therapy to Inform Radiation Therapy Decisions (POWER) Trial: Baseline Patient Beliefs about Breast Cancer and Endocrine Therapy; American Society of Clinical Oncology Meeting 2024, Chicago, IL. (Poster) *Presenting author
